語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Kala Azar in South Asia[electronic r...
~
Jha, T.K.
Kala Azar in South Asia[electronic resource] :current status and sustainable challenges /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
616.9364
書名/作者:
Kala Azar in South Asia : current status and sustainable challenges // edited by Eisei Noiri, T.K. Jha.
其他作者:
Noiri, Eisei.
出版者:
Cham : : Springer International Publishing :, 2016.
面頁冊數:
xx, 309 p. : : ill., digital ;; 24 cm.
Contained By:
Springer eBooks
標題:
Kala-azar - South Asia.
標題:
Biomedicine.
標題:
Parasitology.
標題:
Drug Resistance.
標題:
Veterinary Medicine/Veterinary Science.
標題:
Laboratory Medicine.
標題:
Nephrology.
ISBN:
9783319471013
ISBN:
9783319436111
內容註:
Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients' urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.
電子資源:
http://dx.doi.org/10.1007/978-3-319-47101-3
Kala Azar in South Asia[electronic resource] :current status and sustainable challenges /
Kala Azar in South Asia
current status and sustainable challenges /[electronic resource] :edited by Eisei Noiri, T.K. Jha. - Cham :Springer International Publishing :2016. - xx, 309 p. :ill., digital ;24 cm.
Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients' urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.
ISBN: 9783319471013
Standard No.: 10.1007/978-3-319-47101-3doiSubjects--Topical Terms:
688531
Kala-azar
--South Asia.
LC Class. No.: RC152
Dewey Class. No.: 616.9364
Kala Azar in South Asia[electronic resource] :current status and sustainable challenges /
LDR
:03240nam a2200301 a 4500
001
477185
003
DE-He213
005
20170112135242.0
006
m d
007
cr nn 008maaau
008
181208s2016 gw s 0 eng d
020
$a
9783319471013
$q
(electronic bk.)
020
$a
9783319436111
$q
(paper)
024
7
$a
10.1007/978-3-319-47101-3
$2
doi
035
$a
978-3-319-47101-3
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
RC152
072
7
$a
MMFP
$2
bicssc
072
7
$a
MED103000
$2
bisacsh
082
0 4
$a
616.9364
$2
23
090
$a
RC152
$b
.K14 2016
245
0 0
$a
Kala Azar in South Asia
$h
[electronic resource] :
$b
current status and sustainable challenges /
$c
edited by Eisei Noiri, T.K. Jha.
260
$a
Cham :
$b
Springer International Publishing :
$b
Imprint: Springer,
$c
2016.
300
$a
xx, 309 p. :
$b
ill., digital ;
$c
24 cm.
505
0
$a
Preface. Part I Introduction into Kala-Azar Pathology and Mechanism of Disease in Kala-Azar -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Characteristics of Patients Visiting Suruya Kanta Kala-Azar Research Center in Mymensingh, Bangladesh; Data from a Patient Registry System -- Epidemiology of Drug-Resistant Kala-Azar in India and Neighboring Countries -- Part II Therapeutic Strategy to Deal with Emergence of Drug Resistance -- A Therapeutic Strategy for Treating Visceral Leishmaniasis in Regions with Drug Resistance -- Treatment of Post-kala-azar Dermal Leishmaniasis -- Combination Therapy for Leishmaniasis -- Vaccine Development for Leishmaniasis -- Siccanin is a novel selective inhibitor of trypanosomatid complex II (succinate-ubiquinone reductase) and a potent broad-spectrum anti-trypanosomatid drug candidate -- Challenges in the Diagnosis of Visceral Leishmaniasis on the Indian Subcontinent -- Part III Diagnostic Strategy Enhancing Kala-Azar Elimination Program -- Changes of Leishmania antigens in kala-azar patients' urine after treatment -- Potentiality of Urinary L-FABP Tests to Kala-azar Disease Management -- Antibody Capture Direct Agglutination Test (abcDAT) for Diagnosis of Visceral Leishmaniasis with Urine -- Loop-mediated Isothermal Amplification (LAMP): Molecular Diagnosis for the Field Survey of Visceral Leishmaniasis -- Applicability of Multiplex Real-Time PCR to Visceral Leishmaniasis -- Immunoglobulins in the Pathophysiology of Visceral Leishmaniasis -- Part V Knowledge and Practice for Vector Control in Kala-Azar -- Geographical Distribution and Ecological Aspect of Sand Fly Species in Bangladesh -- The efficacy of long lasting insecticidal nets for leishmaniasis in Asia -- Environmental change and kala-azar with particular reference to Bangladesh -- Part VI. New Challenges in the Kala-azar Elimination Programme -- Drug Safety Monitoring for Liposomal Amphotericin B -- Resolution Mapping of Kala-azar Hot Spots Using GPS Logger and Urinary Antibody Measurements -- Geography and Reality of Kala-azar Endemic in Bangladesh, Analysis Using GIS and Urine-based Mass Screening -- Animal Models of Visceral Leishmaniasis and Applicability to Disease Control -- Pharmacovigilance on Therapeutic Protocols for Visceral Leishmaniasis. Index.
650
0
$a
Kala-azar
$z
South Asia.
$3
688531
650
1 4
$a
Biomedicine.
$3
463454
650
2 4
$a
Parasitology.
$3
463661
650
2 4
$a
Drug Resistance.
$3
466595
650
2 4
$a
Veterinary Medicine/Veterinary Science.
$3
672515
650
2 4
$a
Laboratory Medicine.
$3
463580
650
2 4
$a
Nephrology.
$3
431316
700
1
$a
Noiri, Eisei.
$3
613696
700
1
$a
Jha, T.K.
$3
688530
710
2
$a
SpringerLink (Online service)
$3
463450
773
0
$t
Springer eBooks
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-47101-3
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
多媒體
多媒體檔案
http://dx.doi.org/10.1007/978-3-319-47101-3
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入